Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

759 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Machine learning diagnosis by immunoglobulin N-glycan signatures for precision diagnosis of urological diseases.
Iwamura H, Mizuno K, Akamatsu S, Hatakeyama S, Tobisawa Y, Narita S, Narita T, Yamashita S, Kawamura S, Sakurai T, Fujita N, Kodama H, Noro D, Kakizaki I, Nakaji S, Itoh K, Tsuchiya N, Ito A, Habuchi T, Ohyama C, Yoneyama T. Iwamura H, et al. Among authors: narita s, narita t. Cancer Sci. 2022 Jul;113(7):2434-2445. doi: 10.1111/cas.15395. Epub 2022 May 25. Cancer Sci. 2022. PMID: 35524940 Free PMC article.
Clinical implications of serum N-glycan profiling as a diagnostic and prognostic biomarker in germ-cell tumors.
Narita T, Hatakeyama S, Yoneyama T, Narita S, Yamashita S, Mitsuzuka K, Sakurai T, Kawamura S, Tochigi T, Takahashi I, Nakaji S, Tobisawa Y, Yamamoto H, Koie T, Tsuchiya N, Habuchi T, Arai Y, Ohyama C. Narita T, et al. Among authors: narita s. Cancer Med. 2017 Apr;6(4):739-748. doi: 10.1002/cam4.1035. Epub 2017 Mar 20. Cancer Med. 2017. PMID: 28317343 Free PMC article.
Significance of Serum N-glycan Profiling as a Diagnostic Biomarker in Urothelial Carcinoma.
Oikawa M, Hatakeyama S, Yoneyma T, Tobisawa Y, Narita T, Yamamoto H, Hashimoto Y, Koie T, Narita S, Sasaki A, Tsuchiya N, Habuchi T, Takahashi I, Nakaji S, Ohyama C. Oikawa M, et al. Among authors: narita s, narita t. Eur Urol Focus. 2018 Apr;4(3):405-411. doi: 10.1016/j.euf.2016.11.004. Epub 2016 Nov 22. Eur Urol Focus. 2018. PMID: 28753809
Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].
Hatakeyama S, Koie T, Narita T, Hosogoe S, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C. Hatakeyama S, et al. Among authors: narita t. PLoS One. 2016 Feb 22;11(2):e0149544. doi: 10.1371/journal.pone.0149544. eCollection 2016. PLoS One. 2016. PMID: 26901860 Free PMC article.
The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
Narita T, Koie T, Ookubo T, Mitsuzuka K, Narita S, Yamamoto H, Inoue T, Hatakeyama S, Kawamura S, Tochigi T, Habuchi T, Arai Y, Ohyama C. Narita T, et al. Among authors: narita s. Med Oncol. 2017 Jan;34(1):1. doi: 10.1007/s12032-016-0859-0. Epub 2016 Nov 26. Med Oncol. 2017. PMID: 27889880
Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.
Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C. Kusaka A, et al. Among authors: narita t. Med Oncol. 2017 May;34(5):90. doi: 10.1007/s12032-017-0955-9. Epub 2017 Apr 10. Med Oncol. 2017. PMID: 28397105
Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.
Matsumoto T, Hatakeyama S, Ookubo T, Mitsuzuka K, Narita S, Inoue T, Yamashita S, Narita T, Koie T, Kawamura S, Tochigi T, Tsuchiya N, Habuchi T, Arai Y, Ohyama C. Matsumoto T, et al. Among authors: narita s, narita t. Med Oncol. 2017 Oct 31;34(12):190. doi: 10.1007/s12032-017-1050-y. Med Oncol. 2017. PMID: 29090390
Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution.
Fujita N, Koie T, Hashimoto Y, Narita T, Tobisawa Y, Tanaka T, Noro D, Oikawa M, Hagiwara K, Yoneyama T, Imai A, Yamamoto H, Hatakeyama S, Yoneyama T, Ohyama C. Fujita N, et al. Among authors: narita t. Int Urol Nephrol. 2018 Nov;50(11):1999-2005. doi: 10.1007/s11255-018-1985-8. Epub 2018 Sep 18. Int Urol Nephrol. 2018. PMID: 30229466
Clinical Characterization of Low Prostate-specific Antigen on Prognosis in Patients With Metastatic Castration-naive Prostate Cancer.
Kodama H, Hatakeyama S, Narita S, Takahashi M, Sakurai T, Kawamura S, Hoshi S, Ishida M, Kawaguchi T, Ishidoya S, Shimoda J, Narita T, Sato H, Mitsuzuka K, Tochigi T, Tsuchiya N, Arai Y, Habuchi T, Ohyama C. Kodama H, et al. Among authors: narita s, narita t. Clin Genitourin Cancer. 2019 Dec;17(6):e1091-e1098. doi: 10.1016/j.clgc.2019.05.029. Epub 2019 Sep 10. Clin Genitourin Cancer. 2019. PMID: 31575477
759 results